Archive for November, 2006
Sanofi- Aventis Receives Pediatric Exclusivity for Ambien and … - ag-IP-news Agency
Closed Published by Google Inc. November 30th, 2006 in Google FDA News, Regulatory AffairsSanofi- Aventis Receives Pediatric Exclusivity for Ambien and …ag-IP-news Agency, Jordan - 1 hour agoPARIS - Sanofi-aventis announced on Thursday that the US Food and Drug Administration (FDA) has granted pediatric exclusivity for Ambien (z…
(AFX UK Focus) 2006-11-30 09:03 GMT: Axis-Shield gets US FDA nod for vitamin B12 deficiency test on Abbott’s kit (Interactive Investor)
Closed Published by Yahoo! News Search Results for Food and Drug Admin November 30th, 2006 in Yahoo FDA News, Regulatory AffairsLONDON (AFX) - Diagnostics company Axis-Shield PLC said it has received marketing approval from the US Food and Drug Administration for a test to measure vitamin B12 deficiency, which leads to conditions such as Alzheimer’s disease.
FDA advisers back Celebrex for children despite risks (Boston Globe)
Closed Published by Yahoo! News Search Results for Food and Drug Admin November 30th, 2006 in Yahoo FDA News, Regulatory AffairsChildren as young as 2 who suffer from arthritis can be treated with Celebrex , but to ensure the painkiller doesn’t put them at later risk for heart attacks, their health should be tracked for decades, a Food and Drug Administration advisory panel said yesterday.
Turkey's Eczacibasi May Sell Its Generic-Drug Unit, People Say - Bloomberg
Closed Published by Google Inc. November 30th, 2006 in Google FDA News, Regulatory AffairsTurkey's Eczacibasi May Sell Its Generic-Drug Unit, People SayBloomberg - 2 hours ago… It has asked the US Food and Drug Administration to inspect the sites. FDA approval would increase opportunities to export medicines from Turkey. …
Senators urge probe of drug (Baltimore Sun)
Closed Published by Yahoo! News Search Results for Food and Drug Admin November 30th, 2006 in Yahoo FDA News, Regulatory AffairsThey want Pentagon to determine if Factor VII’s risks outweigh benefits Two U.S. senators called on the Pentagon yesterday to investigate the military’s use of a largely experimental blood-coagulating drug that doctors inject into wounded troops to control bleeding but that has been linked to unexpected and potentially deadly blood clots.
Senators urge probe of drug (Baltimore Sun)
Closed Published by Yahoo! News Search Results for Food and Drug Admin November 30th, 2006 in Yahoo FDA News, Regulatory AffairsThey want Pentagon to determine if Factor VII’s risks outweigh benefits Two U.S. senators called on the Pentagon yesterday to investigate the military’s use of a largely experimental blood-coagulating drug that doctors inject into wounded troops to control bleeding but that has been linked to unexpected and potentially deadly blood clots.
FDA Provides Manufacturing Clearance For Phase III Trial Of Anti-Cancer Drug
Closed Published by FDA - Topix.net November 30th, 2006 in UncategorizedProgen Industries today announced it has received notification from the U.S. FDA that the appropriate CMC procedures have been put in place to progress its anti-cancer drug PI-88 to Phase III clinical trials.
Comment
Food And Drug Law Institute Sponsors National Colloquium On Access To Unapproved Drugs (Medical News Today)
Closed Published by Yahoo! News Search Results for Food and Drug Admin November 30th, 2006 in Yahoo FDA News, Regulatory AffairsShould terminally ill patients be allowed access to drugs not approved by the Food and Drug Administration? That is the question a panel of experts will discuss and debate at a landmark Colloquium, Whose Life Is It, Anyway?, sponsored by the Food and Drug Law Institute (FDLI), Feb. 27, 2007, in Washington, D.C. [click link for full article]
BUSINESS TRENDS: Drug firm executive shares research - Cherry Hill Courier Post
Closed Published by Google Inc. November 30th, 2006 in Google FDA News, Regulatory AffairsBUSINESS TRENDS: Drug firm executive shares researchCherry Hill Courier Post, NJ - 16 hours ago… for AstraZeneca. Apruzzese shared the results of a research project by his company and the US Food And Drug Administration. The …
FDA Advisory Committee To Consider Navy’s Proposed ‘Resus’ Trauma Trial In Open Session On December 14, 2006 (Medical News Today)
Closed Published by Yahoo! News Search Results for Food and Drug Admin November 30th, 2006 in Yahoo FDA News, Regulatory AffairsBiopure Corporation (Nasdaq: BPUR) announced today that the Food and Drug Administration’s (FDA) Blood Products Advisory Committee will meet in open session on December 14, 2006 to discuss the Navy’s proposed RESUS clinical trial of Biopure’s investigational oxygen therapeutic Hemopure(R) [he [click link for full article]
Analysis: Bright Future for Novartis (RedNova)
Closed Published by Yahoo! News Search Results for Food and Drug Admin November 30th, 2006 in Yahoo FDA News, Regulatory AffairsBy STEVE MITCHELL Novartis said toxicity concerns may delay the Food and Drug Administration’s action on Galvus for diabetes and Tekturna for hypertension, but analysts still see a positive future for the company.
Danger: ; Methadone Warning (RedNova)
Closed Published by Yahoo! News Search Results for Food and Drug Admin November 30th, 2006 in Yahoo FDA News, Regulatory AffairsBy Gzedit FINALLY, the U.S. Food and Drug Administration is warning doctors and patients of the deadly potential of methadone, and has revised dosage information included with the drug. This action, although late, may save lives.
Frank ‘The Fetus’ Strikes Again (Austin Chronicle)
Closed Published by Yahoo! News Search Results for Food and Drug Admin November 29th, 2006 in Yahoo FDA News, Regulatory AffairsSeemingly undaunted by his failure to push through legislation in 2005 that sought to protect ” pharmacists of conscience ” (that is, pro-life pill counters) from having to fill scrips for emergency contraceptives – or by the larger defeat inherent in the U.S. Food and Drug Administration ’s decision to approve over-the-counter sales status for the EC Plan B – Rep.
FDA ruling sends Possis shares up
Closed Published by FDA - Topix.net November 29th, 2006 in UncategorizedShares of Possis Medical Inc. jumped more than 9 percent Wednesday after the medical-device company received government clearance to market a catheter for its AngioJet product - used to clear blood clots - as a …
Comment
Black Market Dispenses HIV Drugs and Risk Treatment's cost and … - Public Integrity
Closed Published by Google Inc. November 29th, 2006 in Google FDA News, Regulatory AffairsBlack Market Dispenses HIV Drugs and Risk Treatment's cost and …Public Integrity, DC - 1 hour ago… The US government's practice of funding only ARV drugs approved by the US Food and Drug Administration rather than less expensive g…
Search
About
You are currently browsing the Regulatory Affairs Syndicator weblog archives for November, 2006.
Longer entries are truncated. Click the headline of an entry to read it in its entirety.Archives
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- March 2009
- December 2008
- November 2008
- October 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- December 2007
- November 2007
- October 2007
- September 2007
- August 2007
- July 2007
- June 2007
- May 2007
- April 2007
- March 2007
- February 2007
- January 2007
- December 2006
- November 2006
- October 2006
- September 2006
- August 2006
- July 2006
- June 2006
- May 2006
- April 2006
- March 2006
- February 2006
- January 2006
- December 2005
- November 2005
- October 2005
- September 2005
- August 2005
- July 2005
- May 2005
- January 2005
- December 1969
Categories
- AAPS PharmSciTech (1)
- AIDS Alert (1)
- Am J Cardiol (1)
- Am J Hosp Pharm (1)
- Am Pharm (1)
- Ann Intern Med (1)
- Ann Pharmacother (2)
- Ann Thorac Surg (1)
- Behav Brain Res (1)
- Biomed Instrum Technol (1)
- Can J Cardiol (1)
- Circulation (1)
- Clin Chem (1)
- Compend Contin Educ Dent (1)
- Congest Heart Fail (1)
- Conn Med (1)
- Consumers (2)
- Contracept Technol Update (1)
- Curr Concepts Hosp Pharm Manage (1)
- Curr Urol Rep (1)
- Dentomaxillofac Radiol (1)
- Drug Intell Clin Pharm (1)
- Expert Rev Med Devices (1)
- FDA Consum (1)
- Fed Regist (8)
- Food Drug Law J (2)
- Food Safety (188)
- Google FDA News (15596)
- Health Devices (2)
- Healthc Hazard Mater Manage (2)
- Heart Rhythm (1)
- Home Healthc Nurse (1)
- Hosp Mater Manage Q (1)
- Hosp Technol Ser (1)
- Hospitals (1)
- Int J Health Serv (1)
- Int J Trauma Nurs (1)
- Int Psychogeriatr (1)
- J Allergy Clin Immunol (1)
- J Am Board Fam Pract (1)
- J Am Coll Dent (1)
- J Am Coll Surg (1)
- J Am Diet Assoc (3)
- J Am Med Inform Assoc (1)
- J Am Pharm Assoc (1)
- J Can Dent Assoc (2)
- J Card Fail (1)
- J Clin Eng (1)
- J Clin Pharmacol (1)
- J Drugs Dermatol (1)
- J Emerg Med (1)
- J Endod (1)
- J Environ Pathol Toxicol (1)
- J Expo Anal Environ Epidemiol (1)
- J Food Prot (1)
- J Healthc Mater Manage (1)
- J Immunol (1)
- J Neural Eng (1)
- J Neurosurg Spine (1)
- J Proteome Res (1)
- J Thorac Cardiovasc Surg (1)
- J Vasc Surg (1)
- JAMA (3)
- Lancet (3)
- Magn Reson Med (1)
- Med Device Technol (6)
- Med Law (1)
- Med World News (1)
- Medical Devices (38)
- MMWR Morb Mortal Wkly Rep (1)
- Mod Healthc (3)
- NIH (354)
- Nippon Hoshasen Gijutsu Gakkai Zasshi (1)
- NY Times (Print) (2)
- OR Manager (1)
- Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1)
- Pa Med (1)
- Pacing Clin Electrophysiol (1)
- Patient Safety (143)
- PDA J Pharm Sci Technol (1)
- Pediatrics (1)
- Public Health Rep (1)
- PubMed Medical Devices (42)
- PubMed Recall (86)
- Purch Adm (2)
- Recalls (202)
- Regulatory Affairs (32687)
- Rev Elev Med Vet Pays Trop (1)
- Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu (1)
- Stud Health Technol Inform (1)
- Surg Endosc (1)
- Time (1)
- Transfus Med Rev (1)
- Transfusion (1)
- Uncategorized (4476)
- US News World Rep (1)
- Vaccine (1)
- Value Health (1)
- Women Health (1)
- Yahoo FDA News (8060)
Content Cloud
advisers american announces approval arthritis backs boston canada chronicle debate europe faster financial francisco gilead helps home inquirer jose journal marketwatch mercury panel pfizer philadelphia pill press prevent preventive release report review risks star street study test times used wall washington york